Description

The Hepatic Fibrosis Test YGA1357 // YGA1361 is an indispensable diagnostic tool engineered for the early detection of liver fibrosis, a condition that can severely impair liver function if left unchecked. However, timely detection can lead to reversibility, underscoring its critical importance. This test kit evaluates key biomarkers such as PIIINP, CIV, LN, HA, and CG, delivering a precise assessment of fibrosis levels. Compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, it ensures superior sensitivity and accuracy, equipping clinicians with the necessary information to make informed decisions about interventions and treatments.

Market Price

The Hepatic Fibrosis Test YGA1357 // YGA1361 is priced competitively, ranging from $86 to $100 per test based on packaging options like 50T/BOX and 100T/BOX. With volume discounts available, laboratories and healthcare facilities can make this test an economical choice for widespread testing. This cost-efficiency, paired with accurate results, makes it an ideal option for extensive liver assessments.

Frequently Asked Questions

• What markers are tested in the Hepatic Fibrosis Test YGA1357? This test evaluates levels of PIIINP, CIV, LN, HA, and CG biomarkers, providing indicators of liver damage and the extent of fibrosis.

• How is the Hepatic Fibrosis Test performed? The test uses CLIA technology and requires Chemiluminescence Immunoassay Analyzers for sample analysis, ensuring high sensitivity and accuracy.

• How should the test kit be stored? The kit should be stored between 2-8°C to maintain its integrity and accuracy.

Advantages and Disadvantages

Advantages:

• Facilitates early detection of liver fibrosis, potentially improving patient outcomes through timely interventions.
• Offers high accuracy and sensitivity, providing reliable results with minimal false negatives.
• Compatible with automated analyzers, enhancing laboratory efficiency and throughput.
• Evaluates a comprehensive range of biomarkers for a holistic liver function assessment.

Disadvantages:

• Requires specific storage conditions (2-8°C), which may affect portability.
• Not suitable for diagnosing advanced liver diseases, where alternative methods might be more effective.

Use of the Product in the Field

The Hepatic Fibrosis Test YGA1357 // YGA1361 is widely employed in clinical laboratories, hepatology clinics, and research institutions. It plays a crucial role in the early-stage diagnosis of liver fibrosis, enabling effective monitoring and intervention before the condition develops into irreversible cirrhosis. This test is essential for routine liver screenings, particularly for patients at higher risk due to factors like chronic alcohol consumption, viral infections, or metabolic disorders. Its user-friendly design and compatibility with automated systems make it perfect for high-volume testing in diverse healthcare environments.

Recommendations

• Ensure the kit is stored at the recommended temperature of 2-8°C to maintain reagent accuracy.
• Integrate the test into automated systems for faster processing and minimal errors.
• Regularly use the test for at-risk populations to improve early detection and enhance patient care outcomes.

Technical Specifications